Blogs

Immune Monitor - November 2022

By SITC Communications posted 11-24-2022 00:00

  

A Message from the President


Dear Colleagues,

Somehow, the 37th Annual Meeting & Pre-Conference Programs (SITC 2022) has already come and gone. I would like to start this message with a sincere thank you to all of the attendees, supporters, organizers, faculty, staff and other volunteers who helped make our society’s meeting a record breaking success. More than 7,400 professionals in the cancer research community gathered in Boston and virtually Nov. 8–12 to present and hear the latest data and research from more than 1,500 abstracts SITC received.

We heard an amazing Keynote Address from Padmanee Sharma, MD, PhD on the future of neoadjuvant immunotherapy, honored many of the SITC award winners and inducted the second class of the Fellows of the Academy of Immuno-Oncology (FAIO). Additionally, we saw many new activities including new Early Career Scientist events as well as a mentorship and networking program for underrepresented minority undergraduates in STEM. Don’t forget, for all those who registered for SITC 2022, you can access program presentations on-demand through Jan. 9, 2023 on the SITC 2022 virtual platform.

Dr. Crystal Mackall of Stanford University, was also in attendance at SITC 2022. She sat on a panel – along with Dr. Carl June, Dr. Steven A. Rosenberg and Dr. Michel Sadelain – that honored the work of Dr. Zelig Eshhar, as well as co-chaired a session on immunotherapy in special patient populations. However, before I saw Dr. Mackall in person at the meeting, we sat down virtually for this month’s Fireside Chat. We explore her background and dive into her stellar work with identifying an essential role for the thymus in human T cell regeneration and more. Click the video below to listen to our full conversation.


Thanks for tuning in. For those of you who celebrate Thanksgiving, I hope it was enjoyable! Check back next month for my last Fireside Chat as SITC president.
Sincerely,
Patrick Hwu, MD
SITC President

 

2023 Advances in Cancer Immunotherapy™ (ACI) Live  Programming Registration NOW Open  
Registration for SITC’s 10th year of ACI live programming is now available. The coming year’s series will feature 15 topic-driven programs, approximately 4 hours in length, offering CME, CNE, CPE and MOC credit at no cost for clinicians. All of these programs will be available to attend virtually, with 6 of them hosted in-person, as well. 



March 10, 2023 I 2-6 pm ET I In-Person in Houston, TX and Hosted Virtually through Zoom Webinar
Organizers:
Adi Diab, MD
The University of Texas MD Anderson Cancer Center
Greg Lizee, PhD
The University of Texas MD Anderson Cancer Center
Rahul A. Sheth, MD
The University of Texas MD Anderson Cancer Center

Feb. 24, 2023 I 1-5 pm ET I Hosted through Zoom Webinar
Organizers:
Pavani Chalasani, MD, MPH 
University of Arizona Cancer Center
Peter Kabos, MD
University of Colorado Cancer Center
Cancer Immunotherapy Winter School I Jan. 17–21, 2023 Austin, TX or Virtual
SITC’s Cancer Immunotherapy Winter School (CIWS) is a comprehensive cancer immunotherapy education program, led by experts in the field. Participants will improve their understanding of the core principles of tumor immunology and cancer immunotherapy and examine developing areas in the field.
Early registration rates are available through Dec. 12.
Register now and save up to $200 off the regular rates!
Cancer Immunotherapy Winter School is a perfect fit for individuals working in academic, clinical, industry and government settings who are early-to-mid-career scientists and clinicians, or those who are new to the field.

Send in Proposal Ideas by Dec. 16
Twice a year, SITC leadership entertains proposal ideas from its members. This is an opportunity to help shape the future of SITC webinars, workshops, Annual Meeting sessions and more. 
Submit a Proposal


Volunteer Opportunities Open Now!
SITC’s strength comes from the generous commitment and dedication of its members. By donating your time and expertise through member volunteer opportunities, you can make considerable contributions to the cancer immunotherapy field while enhancing your own research and expanding your professional network. 

Permalink